Structure-guided insights into potential function of novel genetic variants in the malaria vaccine candidate PfRh5

Archive ouverte

Mangou, Khadidiatou | Moore, Adam, J. | Thiam, Laty Gaye | Ba, Aboubacar | Orfanó, Alessandra | Desamours, Ife | Ndegwa, Duncan Ndungu | Goodwin, Justin | Guo, Yicheng | Sheng, Zizhang | Patel, Saurabh, D. | Diallo, Fatoumata | Sene, Seynabou, D. | Pouye, Mariama, N. | Faye, Awa Thioub | Thiam, Alassane | Nunez, Vanessa | Diagne, Cheikh Tidiane | Sadio, Bacary Djilocalisse | Shapiro, Lawrence | Faye, Ousmane | Mbengue, Alassane | Bei, Amy, K.

Edité par CCSD ; Nature Publishing Group -

International audience. The recent stall in the global reduction of malaria deaths has made the development of a highly effective vaccine essential. A major challenge to developing an efficacious vaccine is the extensive diversity of Plasmodium falciparum antigens. While genetic diversity plays a major role in immune evasion and is a barrier to the development of both natural and vaccine-induced protective immunity, it has been under-prioritized in the evaluation of malaria vaccine candidates. This study uses genomic approaches to evaluate genetic diversity in next generation malaria vaccine candidate PfRh5. We used targeted deep amplicon sequencing to identify non-synonymous Single Nucleotide Polymorphisms (SNPs) in PfRh5 (Reticulocyte-Binding Protein Homologue 5) in 189 P. falciparum positive samples from Southern Senegal and identified 74 novel SNPs. We evaluated the population prevalence of these SNPs as well as the frequency in individual samples and found that only a single SNP, C203Y, was present at every site. Many SNPs were unique to the individual sampled, with over 90% of SNPs being found in just one infected individual. In addition to population prevalence, we assessed individual level SNP frequencies which revealed that some SNPs were dominant (frequency of greater than 25% in a polygenomic sample) whereas most were rare, present at 2% or less of total reads mapped to the reference at the given position. Structural modeling uncovered 3 novel SNPs occurring under epitopes bound by inhibitory monoclonal antibodies, potentially impacting immune evasion, while other SNPs were predicted to impact PfRh5 structure or interactions with the receptor or binding partners. Our data demonstrate that PfRh5 exhibits greater genetic diversity than previously described, with the caveat that most of the uncovered SNPs are at a low overall frequency in the individual and prevalence in the population. The structural studies reveal that novel SNPs could have functional implications on PfRh5 receptor binding, complex formation, or immune evasion, supporting continued efforts to validate PfRh5 as an effective malaria vaccine target and development of a PfRh5 vaccine.

Suggestions

Du même auteur

Plasmodium infection is associated with cross‑reactive antibodies to carbohydrate epitopes on the SARS‑CoV‑2 Spike protein

Archive ouverte | Lapidus, Sarah | CCSD

International audience. Sero-surveillance can monitor and project disease burden and risk. However, SARS-CoV-2 antibody test results can produce false positive results, limiting their efficacy as a sero-surveillance...

Monitoring molecular markers associated with antimalarial drug resistance in south-east Senegal from 2021 to 2023

Archive ouverte | Wade, Alioune | CCSD

International audience. Abstract Background Since 2006, artemisinin-based combination therapies (ACTs) have been introduced in Senegal in response to chloroquine resistance (CQ-R) and have shown high efficacy agains...

Identification of an in vitro artemisinin-resistant Plasmodium falciparum kelch13 R515K mutant parasite in Senegal

Archive ouverte | Sene, Seynabou | CCSD

International audience. The emergence of artemisinin partial resistance (ART-r) in Plasmodium falciparum malaria parasites has substantially compromised the efficacy of antimalarial treatments across southeast Asia ...

Chargement des enrichissements...